Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification Source: Eur Respir J 2012; 39: 478-486 Year: 2012
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019
Surgical management of rare malignant tumours of lungs: lessons learned Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Sublobar resections vs lobectomy for early stage lung cancer: where do we stand? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020
Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer Source: Eur Respir J 2013; 42: 1119-1133 Year: 2013
Surgical and endoscopic management of patients with pulmonary emphysema in thoracic division: Lessons learned Source: Annual Congress 2010 - Video-assisted thorascopic surgery, novel technical devices and tracheal problems Year: 2010
Surgical management of early lung cancer: the surgeon's view Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005
Therapeutic options for operated adenocarcinoma patients in stages I or II Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner Source: Virtual Congress 2021 – Thoracic oncology Year: 2021
International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019 Year: 2020
Is surgical resection of M1a lung adenocarcinoma with metastatic pleural nodules really a useless choice? Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Surgery of lung cancer in elderly patients: lessons learned Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005
New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches Source: Virtual Congress 2021 – Thoracic oncology Year: 2021